| 60492-0075-4 |
60492-0075 |
PLASMA DERIVATIVE |
BAT |
Botulism Antitoxin Heptavalent |
LIQUID |
INTRAVENOUS |
20130301 |
N/A |
BLA |
BLA125462 |
Emergent BioSolutions Canada Inc |
EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2 |
4500 [iU]/10mL; 3300 [iU]/10mL; 3000 [iU]/10mL; 600 [iU]/10mL; 5100 [iU]/10mL; 3000 [iU]/10mL; 600 [iU]/10mL |
1 VIAL, GLASS in 1 CARTON (60492-0075-4) / 50 mL in 1 VIAL, GLASS (60492-0075-1) |
| 60492-0075-2 |
60492-0075 |
PLASMA DERIVATIVE |
BAT |
Botulism Antitoxin Heptavalent |
LIQUID |
INTRAVENOUS |
20130301 |
N/A |
BLA |
BLA125462 |
Emergent BioSolutions Canada Inc |
EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2 |
4500 [iU]/10mL; 3300 [iU]/10mL; 3000 [iU]/10mL; 600 [iU]/10mL; 5100 [iU]/10mL; 3000 [iU]/10mL; 600 [iU]/10mL |
6 VIAL, GLASS in 1 CARTON (60492-0075-2) / 50 mL in 1 VIAL, GLASS (60492-0075-1) |